Jefferies Group's CGON Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 769,947 shares of CG Oncology, Inc. (CGON) worth $54.7 M, representing 0.36% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in CGON, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's CG Oncology (CGON) Holding Value Over Time
Track share changes against reported price movement
Quarterly CG Oncology (CGON) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +769,947 | New Buy | 769,947 | $71.05 |
Jefferies Group's CG Oncology Investment FAQs
Jefferies Group first purchased CG Oncology, Inc. (CGON) in Q2 2026, acquiring 769,947 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held CG Oncology, Inc. (CGON) for 1 quarters since Q2 2026.
Jefferies Group's largest addition to CG Oncology, Inc. (CGON) was in Q2 2026, adding 769,947 shares worth $54.7 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 769,947 shares of CG Oncology, Inc. (CGON), valued at approximately $54.7 M.
As of the Q2 2026 filing, CG Oncology, Inc. (CGON) represents approximately 0.36% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in CG Oncology, Inc. (CGON) was 769,947 shares, as reported at the end of Q2 2026.